These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 8383961)

  • 1. Influence of B-haplotype on the relative efficacy of Marek's disease vaccines of different serotypes.
    Bacon LD; Witter RL
    Avian Dis; 1993; 37(1):53-9. PubMed ID: 8383961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines.
    Bacon LD; Witter RL
    Avian Dis; 1994; 38(1):65-71. PubMed ID: 8002902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B haplotype influence on the relative efficacy of Marek's disease vaccines in commercial chickens.
    Bacon LD; Witter RL
    Poult Sci; 1994 Apr; 73(4):481-7. PubMed ID: 8202426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host genetic resistance to Marek's disease sustains protective efficacy of herpesvirus of turkey in both experimental and commercial lines of chickens.
    Chang S; Xie Q; Dunn JR; Ernst CW; Song J; Zhang H
    Vaccine; 2014 Apr; 32(16):1820-7. PubMed ID: 24530405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of turkey herpesvirus vaccination on the B-haplotype effect on Marek's disease resistance in 15.B-congenic chickens.
    Bacon LD; Witter RL
    Avian Dis; 1992; 36(2):378-85. PubMed ID: 1320867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference between influences of homologous and heterologous maternal antibodies on response to serotype-2 and serotype-3 Marek's disease vaccines.
    King D; Page D; Schat KA; Calnek BW
    Avian Dis; 1981; 25(1):74-81. PubMed ID: 6268052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
    Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
    Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity to infectious bronchitis in broilers vaccinated against Marek's disease either in ovo or at hatch and against infectious bronchitis at hatch.
    Avakian AP; Wakenell PS; Grosse D; Whitfill CE; Link D
    Avian Dis; 2000; 44(3):536-44. PubMed ID: 11007000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of vaccinal immunity against Marek's disease.
    Witter RL; Offenbecker L
    Avian Dis; 1978; 22(3):396-408. PubMed ID: 211999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marek's disease: a model for protection against herpesvirus-induced tumours.
    Schat KA
    Cancer Surv; 1987; 6(1):1-37. PubMed ID: 2825984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization against Marek's disease transplantable cell lines.
    Nazerian K; Witter RL
    Avian Dis; 1984; 28(1):160-7. PubMed ID: 6326737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of six homozygous MHC-B haplotype populations associated with susceptibility to Marek's disease in Chinese specific pathogen-free BWEL chickens.
    Gao C; Han L; Han J; Liu J; Jiang Q; Guo D; Qu L
    Infect Genet Evol; 2015 Jan; 29():15-25. PubMed ID: 25445653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Marek's disease vaccine.
    Ben-Nathan D; Lustig S
    Adv Biotechnol Processes; 1990; 14():347-65. PubMed ID: 2171556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of chickens against very virulent infectious bursal disease virus (IBDV) and Marek's disease virus (MDV) with a recombinant MDV expressing IBDV VP2.
    Tsukamoto K; Kojima C; Komori Y; Tanimura N; Mase M; Yamaguchi S
    Virology; 1999 May; 257(2):352-62. PubMed ID: 10329546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marek's disease in turkeys: lack of protection by vaccination.
    Elmubarak AK; Sharma JM; Witter RL; Sanger VL
    Am J Vet Res; 1982 Apr; 43(4):740-2. PubMed ID: 6280536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of serologically defined major histocompatibility complex haplotypes on Marek's disease resistance in commercially bred White Leghorn chickens.
    Blankert JJ; Albers GA; Briles WE; Vrielink-van Ginkel M; Groot AJ; te Winkel GP; Tilanus MG; van der Zijpp AJ
    Avian Dis; 1990; 34(4):818-23. PubMed ID: 2282011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.